本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Conduit Pharmaceuticals Inc.

2.92
+0.12004.29%
盘后2.92-0.0017-0.06%16:50 EDT
成交量:16.43万
成交额:46.95万
市值:278.04万
市盈率:-0.01
高:2.93
开:2.76
低:2.67
收:2.80
数据加载中...
2024/12/17

重要事件披露

Form 8-K - Current report
2024/12/04

SEC问询函

Form CORRESP - Correspondence
2024/11/25

重要事件披露

Form 8-K - Current report
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/14

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/14

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/06

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/01

重要事件披露

Form 8-K - Current report
2024/10/31

SEC问询函

Form CORRESP - Correspondence
2024/10/18

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/16

重要事件披露

Form 8-K - Current report
2024/10/11

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/19

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/16

SEC问询函

Form CORRESP - Correspondence
2024/09/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/06

重要事件披露

Form 8-K - Current report
2024/09/04

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933